Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Hyaluronic Acid for Atrophic Vaginitis
NCT02014428Phase 4Completed
- Sponsor
- AGUNCO Obstetrics and Gynecology Centre
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by AGUNCO Obstetrics and Gynecology Centre. Primary endpoint: Atrophic vaginal changes at 3 months. Status: completed.
Beyond the preview
Go deeper on NCT02014428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014428.